Surgery Partners Q3 Earnings Forecast Decreased by KeyCorp

Surgery Partners, Inc. (NASDAQ:SGRY) – Equities researchers at KeyCorp lowered their Q3 2026 earnings estimates for shares of Surgery Partners in a research note issued to investors on Monday, October 26th. KeyCorp analyst M. Gillmor now anticipates that the company will post earnings per share of ($0.13) for the quarter, down from their previous forecast of ($0.12). The consensus estimate for Surgery Partners’ current full-year earnings is $0.25 per share. KeyCorp also issued estimates for Surgery Partners’ Q4 2026 earnings at ($0.08) EPS, FY2026 earnings at $0.07 EPS and FY2027 earnings at ($0.21) EPS.

A number of other research firms have also commented on SGRY. Benchmark restated a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Raymond James Financial set a $23.50 target price on shares of Surgery Partners in a report on Monday, October 26th. TD Cowen reiterated a “buy” rating and issued a $19.00 target price on shares of Surgery Partners in a research note on Friday, September 18th. Royal Bank Of Canada downgraded shares of Surgery Partners from a “moderate buy” rating to a “hold” rating and set a $23.50 price target for the company. in a report on Monday, October 26th. Finally, Cantor Fitzgerald downgraded shares of Surgery Partners from an “overweight” rating to a “hold” rating in a report on Monday, October 26th. Four equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $20.14.

Surgery Partners Stock Down 0.4%

Shares of NASDAQ SGRY opened at $23.12 on Tuesday. The stock has a market capitalization of $3.03 billion, a PE ratio of 116.20, a P/E/G ratio of 7.19 and a beta of 1.90. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.95 and a quick ratio of 1.78. The business’s fifty day moving average price is $15.30 and its 200-day moving average price is $14.68. Surgery Partners has a one year low of $11.41 and a one year high of $23.37.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.04. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%. The company had revenue of $848.90 million during the quarter, compared to analyst estimates of $830.03 million. During the same period in the prior year, the company posted $0.17 earnings per share. Surgery Partners’s quarterly revenue was up 2.7% on a year-over-year basis.

Insider Transactions at Surgery Partners

In related news, Director Teresa DeLuca purchased 10,000 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was acquired at an average price of $14.35 per share, with a total value of $143,500.00. Following the purchase, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is currently owned by insiders.

Institutional Trading of Surgery Partners

A number of hedge funds have recently made changes to their positions in the stock. Vise Technologies Inc. bought a new stake in shares of Surgery Partners in the 3rd quarter worth approximately $191,000. State of Wyoming grew its holdings in shares of Surgery Partners by 51.4% during the 3rd quarter. State of Wyoming now owns 23,568 shares of the company’s stock valued at $327,000 after purchasing an additional 7,997 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in Surgery Partners in the 3rd quarter worth $426,000. Inspire Investing LLC raised its position in Surgery Partners by 10.1% in the 3rd quarter. Inspire Investing LLC now owns 44,768 shares of the company’s stock worth $621,000 after purchasing an additional 4,099 shares during the period. Finally, TD Waterhouse Canada Inc. lifted its stake in Surgery Partners by 18.3% in the third quarter. TD Waterhouse Canada Inc. now owns 196,887 shares of the company’s stock worth $2,601,000 after purchasing an additional 30,476 shares during the last quarter.

Key Headlines Impacting Surgery Partners

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Bon Secours Mercy Health’s proposed $23.50-per-share acquisition provides a clear valuation reference and supports the share price. Bain Capital, Surgery Partners’ largest shareholder, plans to roll its equity into the combined company, signaling substantial shareholder participation. Surgery Partners stock enters take-private focus after HealthSpan deal
• Neutral Sentiment: The consensus price target was raised 15.45% to $22.61, reflecting improved valuation expectations, but the target is below the merger offer and therefore provides limited incremental support while the transaction remains pending. Surgery Partners consensus price target increased by 15.45% to $22.61
• Negative Sentiment: KeyCorp reduced its FY2026 EPS forecast to $0.07 from $0.16 and cut its FY2027 forecast to a $0.21-per-share loss from expected earnings of $0.13. It also lowered its Q3 2026 estimate to a $0.13 loss, while forecasting a $0.08 loss for Q4. These revisions point to weaker near-term profitability than previously expected.
• Negative Sentiment: Multiple law firms are investigating the $23.50 merger, including whether Surgery Partners’ directors breached fiduciary duties and whether the transaction adequately serves shareholders. Such investigations may increase deal uncertainty, although these notices do not by themselves indicate that wrongdoing occurred. SGRY shareholder merger investigation Scott+Scott Surgery Partners investor alert

About Surgery Partners

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.